Last reviewed · How we verify
NCT07399912: ENHANCe
Engaging Home-monitored Assessment to Navigate Clinical Decision-making
NA trial testing ENHANCe app in Hypertension,Essential in 116 participants. Enrolling by invitation.
1 October 2026
Quick facts
| Lead sponsor | SingHealth Polyclinics |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 116 |
| Start date | 1 October 2025 |
| Primary completion | 1 October 2026 |
| Estimated completion | 1 October 2026 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- ENHANCe app
- Teaching and training
- Usual care
Conditions studied
- Hypertension,Essential — all drugs for Hypertension,Essential →
Sponsor
SingHealth Polyclinics
Who can join
21 and older, any sex, with Hypertension,Essential. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is testing a new app called ENHANCe, which is designed to help family doctors manage patients with high blood pressure using readings taken at home.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07399912
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypertension,Essential
Currently open trials in the same condition.
- NCT05067998 — The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature · recruiting
- NCT06461273 — Food is Medicine vs Lifestyle Medicine For Cardiovascular Kidney Metabolic (CKM) Syndrome · NA · active not recruiting
- NCT06205628 — Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension · Phase 1 · active not recruiting
- NCT04505618 — Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease · NA · recruiting
- NCT04625569 — Genetic of Response to Acute Saline Load Test in Hypertension (Naload) · recruiting
Other SingHealth Polyclinics trials
Trials by the same sponsor.
- NCT07004231 — Using Gout Buddy to Enhance Gout Management · NA · not yet recruiting
- NCT06607497 — Better Risk Perception Via Patient Similarity to Control Hyperglycemia and Sustained by Telemonitoring · NA · active not recruiting
- NCT06377345 — Remote Patient Monitoring Solution for Chronic Respiratory Disease Management · NA · recruiting
- NCT06205303 — Interventional Study to Improve Medication Adherence Using Patient Decision Aid · NA · recruiting
- NCT06837428 — Peer Comparison-based Risk Communication · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07399912 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by SingHealth Polyclinics
- Last refreshed: 10 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07399912.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing